KMT2A and acute lymphoblastic leukemia: For example, acute lymphoblastic leukemia (ALL) is a heterogeneous disease, including several subtypes (T-ALL, E2A-PBX1, BCR-ABL, TEL-AML1, MLL) differing in their response to chemotherapy [7]–[9].